Reuters logo
BRIEF-Shenzhen Hepalink Pharma plans asset acquisition of 2.4 bln yuan via share issue
September 11, 2017 / 12:56 PM / 15 days ago

BRIEF-Shenzhen Hepalink Pharma plans asset acquisition of 2.4 bln yuan via share issue

Sept 11 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd

* Says it plans to buy Shenzhen Topknow Industry and Development for 2.4 billion yuan ($367.96 million) via share issue

Source text in Chinese: bit.ly/2wVRet8

Further company coverage: ($1 = 6.5224 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below